07 - HCT Practice Guidelines for MDS, Pt. 2: Increasing Access and Shared Care

In this two-part episode, Zachariah DeFilipp, MD, and Andrew Brunner, MD, with Massachusetts General Hospital discuss their findings on a committee of the American Society for Transplantation and Cellular Therapy (ASTCT) to publish an evidence-based review on guidelines for the use of allogeneic hematopoietic cell transplantation in the management and treatment of myelodysplastic syndromes (MDS) from the perspective of both transplant and hematology/oncology.

In Part II: Increasing Access and Shared Care, experts share insights into MDS treatment to assist both hematology/oncology practices and transplant centers in improving HCT access through shared care, especially for older patients with MDS.

To read bios on the panelists and to access additional resources related to this episode, visit Our Site.